First Cardiology Clinic, University of Athens, Hippokration Hospital, Athens, Greece.
Am J Kidney Dis. 2010 Jun;55(6):1050-9. doi: 10.1053/j.ajkd.2009.11.024. Epub 2010 Feb 26.
Asymmetric dimethylarginine (ADMA) and subclinical inflammation are associated with atherosclerosis progression, whereas microalbuminuria is an established index of hypertensive organ damage.
Cross-sectional.
SETTING & PARTICIPANTS: In an outpatient hypertensive unit, 296 nondiabetic and untreated participants with hypertension were studied. Participants with atherosclerotic cardiovascular disease, severe valvulopathy, congestive heart failure, presence of neoplastic or other concurrent systemic disease, atrial fibrillation, serum creatinine level > 1.5 mg/dL in men and > 1.4 mg/dL in women, and urinary albumin excretion > 300 mg/24 h were excluded.
ADMA and high-sensitivity C-reactive protein (hs-CRP) levels.
Albuminuria assessed using albumin-creatinine ratio (ACR).
Participants underwent ambulatory blood pressure monitoring, echocardiography, routine assessment of metabolic profile, ADMA, and hs-CRP, whereas ACR was determined as the mean of 3 values in nonconsecutive morning spot urine samples.
64 participants had an ACR of 30-300 mg/g. Stratification based on ADMA level showed that participants with hypertension in quartile [Q] 4 compared with those in Q3, Q2, and Q1 showed the highest ACRs (53.2 vs 31.2 vs 30.4 vs 16.7 mg/g; P < 0.008 for all). Moreover, stratification based on hs-CRP level showed that participants with hypertension in Q4 (69.8% had microalbuminuria) showed the highest ACRs (72.2 vs 25.6, 16.2, and 19.2 mg/g for Q3, Q2, and Q1, respectively; P < 0.008 for all). Stepwise regression analysis showed that age, 24-hour systolic blood pressure, hs-CRP level, ADMA level, and the interaction of hs-CRP with ADMA were independent predictors of ACR (R(2) = 0.674; P < 0.001).
Cross-sectional study.
In patients with untreated essential hypertension, increased hs-CRP and ADMA levels are associated with microalbuminuria, suggesting the involvement of inflammation and endothelial dysfunction in vascular and kidney damage.
不对称二甲基精氨酸(ADMA)和亚临床炎症与动脉粥样硬化进展有关,而微量白蛋白尿是高血压器官损害的既定指标。
横断面研究。
在门诊高血压病房中,研究了 296 名未接受糖尿病和治疗的高血压患者。排除了患有动脉粥样硬化性心血管疾病、严重瓣膜病、充血性心力衰竭、存在肿瘤或其他同时存在的系统性疾病、心房颤动、男性血清肌酐水平>1.5mg/dL 和女性>1.4mg/dL 以及尿白蛋白排泄量>300mg/24h 的患者。
ADMA 和高敏 C 反应蛋白(hs-CRP)水平。
使用白蛋白/肌酐比值(ACR)评估白蛋白尿。
参与者接受了动态血压监测、超声心动图、代谢谱的常规评估、ADMA 和 hs-CRP,而 ACR 是在非连续早晨随机尿液样本中的 3 个值的平均值。
64 名参与者的 ACR 为 30-300mg/g。根据 ADMA 水平分层显示,与 Q3、Q2 和 Q1 相比,Q4 组的高血压患者的 ACR 最高(53.2 对 31.2 对 30.4 对 16.7mg/g;所有 P<0.008)。此外,根据 hs-CRP 水平分层显示,Q4 组的高血压患者(69.8%有微量白蛋白尿)的 ACR 最高(72.2 对 Q3、Q2 和 Q1 的 25.6、16.2 和 19.2mg/g;所有 P<0.008)。逐步回归分析显示,年龄、24 小时收缩压、hs-CRP 水平、ADMA 水平以及 hs-CRP 与 ADMA 的相互作用是 ACR 的独立预测因子(R2=0.674;P<0.001)。
横断面研究。
在未经治疗的原发性高血压患者中,hs-CRP 和 ADMA 水平升高与微量白蛋白尿有关,提示炎症和内皮功能障碍参与了血管和肾脏损害。